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Background: Selective maintenance of genomic epigenetic imprints during pre-implantation development is
required for parental origin-specific expression of imprinted genes. The Kruppel-like zinc finger protein ZFP57 acts
as a factor necessary for maintaining the DNA methylation memory at multiple imprinting control regions in early
mouse embryos and embryonic stem (ES) cells. Maternal-zygotic deletion of ZFP57 in mice presents a highly
penetrant phenotype with no animals surviving to birth. Additionally, several cases of human transient neonatal
diabetes are associated with somatic mutations in the ZFP57 coding sequence.
Results: Here, we comprehensively map sequence-specific ZFP57 binding sites in an allele-specific manner using
hybrid ES cell lines from reciprocal crosses between C57BL/6J and Cast/EiJ mice, assigning allele specificity to
approximately two-thirds of all binding sites. While half of these are biallelic and include endogenous retrovirus
(ERV) targets, the rest show monoallelic binding based either on parental origin or on genetic background of the
allele. Parental-origin allele-specific binding is methylation-dependent and maps only to imprinting control differentially
methylated regions (DMRs) established in the germline. We identify a novel imprinted gene, Fkbp6, which has a critical
function in mouse male germ cell development. Genetic background-specific sequence differences also influence
ZFP57 binding, as genetic variation that disrupts the consensus binding motif and its methylation is often associated
with monoallelic expression of neighboring genes.
Conclusions: The work described here uncovers further roles for ZFP57-mediated regulation of genomic imprinting
and identifies a novel mechanism for genetically determined monoallelic gene expression.Background
Genomic imprinting is a mechanism of gene regulation
occurring in eutherian mammals and to a lesser extent
marsupials [1–3]. Unlike most autosomal genes that are
expressed from both parental copies, imprinted genes
are transcribed from either the maternal or paternal
chromosome. There are currently over 150 genes known
to be imprinted in mouse, many of which are also
imprinted in human [4, 5]. Correct dosage of imprinted
genes is important for normal development, exemplified
in mouse models [6] and by human genetic syndromes* Correspondence: afsmith@mole.bio.cam.ac.uk
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creativecommons.org/publicdomain/zero/1.0/resulting from epimutation and uniparental disomy affect-
ing imprinted loci [7–11]. Imprinted genes are mostly,
though not exclusively, organized in clusters up to 4 Mb
in size. Each cluster is associated with a germline differen-
tially methylated region (germline DMR), which in all
cases functions as an imprinting control region (ICR) for
multiple genes in the locus. Deletion of this element is
consistent with loss of imprinting at the corresponding re-
gion [12–17]. Four stages of DNA methylation occur at
germline DMRs in mouse: erasure in primordial germ
cells, differential establishment during male and female
gametogenesis, specific targeted maintenance during pre-
implantation development at a time when the majority
of the genome becomes hypomethylated, and post-
implantation maintenance in somatic cells, which provides
the basis for heritable imprinted gene expression [3, 18].ess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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KRAB zinc finger protein ZFP57 in the maintenance of
DNA methylation at multiple imprinted germline DMRs
in mice and human [19, 20]. Failure to maintain DNA
methylation imprints upon maternal-zygotic deletion of
the protein resulted in embryonic lethality by E16.5.
Two recently published studies analyzing ZFP57 null
embryonic stem (ES) cells have also shown hypomethy-
lation at multiple imprinted loci akin to those observed
in the maternal-zygotic mutants [21, 22]. Interestingly,
Zuo and colleagues [22] found that re-introduction of
exogenous ZFP57 in knock-out ES cells did not result in
re-establishment of DNA methylation, indicating irre-
versible loss of epigenetic memory at these DMRs. This
is consistent with studies demonstrating that methyla-
tion of a CpG within the binding motif is necessary for
ZFP57 binding in vitro [21].
The mechanism by which ZFP57 mediates its function is
associated with its interacting partner KAP1, also known
as TRIM28 or TIF1β. A complex containing ZFP57 and
KAP1 appears to co-immunoprecipitate with all three cata-
lytically active DNA methyl transferases as well as the
hemi-methylated DNA binding protein NP95/UHRF1.
Moreover, wild-type but not KRAB domain-deleted ZFP57
(incapable of KAP1 interaction) could substitute for the
endogenous ZFP57 in ES cell DNA methylation mainten-
ance [22]. Finally, a maternal effect mutation of KAP1 was
recently found to result in epigenetic instability, including
frequent loss of methylation at the H19 ICR [23], suggest-
ing a function for KAP1 in maintaining epigenetic marks
during fertilized oocyte to embryo transition.
Utilizing an ES cell line expressing exogenous HA-
tagged ZFP57, Quenneville and colleagues [21] mapped
genomic binding sites of ZFP57 in a non-allele-specific
manner and analyzed specific ICRs in a single hybrid ES
cell line, demonstrating ZFP57 binding to the methyl-
ated allele in each case. Here we perform genome-wide
allele-specific mapping of ZFP57 in mouse reciprocal hy-
brid ES cells using an antibody specific to the endogen-
ous protein. Crucially, the use of reciprocal hybrid lines
allowed us to distinguish true parental-origin allele-
specific binding from binding determined solely by the
genetic sequence. We show that allele-specific binding is
exclusively at imprinted germline DMRs and not at
DMRs derived somatically or germline DMRs that are not
imprinting control regions. Furthermore, analysis of all
ZFP57-bound germline DMRs revealed a highly predictive
power to identify new imprinted loci, including a previ-
ously unreported Fkbp6 imprinted gene on chromosome 5.
In addition, we discover that mouse strain-specific
binding can be specified by sequence variation in the
ZFP57 binding motif itself, and indirectly via genetically
determined differential methylation. Analysis of allele-
specific expression of genes associated with such non-imprinted ZFP57 binding provides the first mechanistic
insight into how genetic variation might lead to monoal-
lelic gene expression via epigenetic mechanisms regu-
lated by ZFP57.
Results
Allele-specific mapping of ZFP57 binding sites
In order to comprehensively map parental allele-specific
ZFP57 binding targets, we performed chromatin immu-
noprecipitation (ChIP) followed by DNA sequencing
(ChIP-seq) in hybrid ES cells derived from reciprocal F1
crosses between C57BL/6J (BL6, B) and Cast/EiJ (Cast,
C) mouse strains (BC and CB lines, respectively) as out-
lined in Fig. 1a. Expression of ZFP57 in these cells was
confirmed by western blotting and found to be compar-
able to a commonly used E14 ES cell line (Fig. S1 in
Additional file 1). ChIP-seq reads were aligned in a
strain-specific manner using a purpose developed allele-
specific alignment pipeline (ASAP) using ~20.5 million
single nucleotide polymorphisms (SNPs) between BL6
and Cast genomes obtained from Biomart and Sanger
mouse genome databases [24, 25] with an overall BL6/
Cast read ratio close to one (Table 1).
A high confidence list of total and allele-specific
ZFP57 binding sites was generated (Fig. S2 in Additional
file 1) followed by extensive independent experimental
validation (Fig. S3 in Additional file 1). In total, 158 en-
dogenous ZFP57 targets were identified in ES cells
(Additional file 2). Strain-specific alignments determined
the allele specificity of each peak and we statistically
assessed read ratios (p < 0.0001) either towards the par-
ental or strain-specific origin of the allele. The remain-
der of the peaks were classed as being either biallelic or
non-informative. In total, significant allelic assignments
were made for approximately two-thirds of binding sites
(Additional file 2; Fig. 1b). A larger proportion of bind-
ing events (54) occurred on both parental alleles, and we
identified an equal number of parental-origin (25 mater-
nal/1 paternal) and strain-specific (17 BL6/9 Cast) in-
stances of monoallelic binding. We found ZFP57 bound
all informative imprinting controlling germline DMRs as-
sociating with the methylated allele (Fig. 1 and Table 2). In
fact, all of the parental allele-specific sites were located
within known imprinted clusters marking the germline
but not somatic DMRs, except for two found on chromo-
some X (expected maternal allele in these two male cell
lines). Examples of biallelic, parental and strain-specific
binding are illustrated in Fig. 1c.
ZFP57 targets are associated with repressive histone
marks and DNA methylation
The distribution of genomic and epigenetic features
around ZFP57-bound genomic regions was analyzed com-
pared with control unbound regions. ZFP57 peaks were
Fig. 1 (See legend on next page.)
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Fig. 1 Allele-specific mapping of Zfp57 binding sites. a Schematic diagram of the experimental design. Example polymorphisms are shown for
the maternal allele-specific binding of ZFP57 over BL6 (A)–Cast (G) SNP. BL6 allele (blue line) is bound by ZFP57 in BC and Cast (brown line) in the CB
line. ASAP allele-specific alignment pipeline devised to map genome-specific reads; ESC embryonic stem cell. b Total number of peaks identified as
being biallelic, parental origin-specific (maternal (Mat) and paternal (Pat)) and strain-specific (BL6 and Cast) based on Fisher’s exact test analysis of
allele-specific reads under each peak. NI refers to non-informative sites due to lack of SNP spanning reads. c UCSC genome browser views (mm9
assembly) of data showing parental allele-specific binding at the paternally methylated IG-DMR (top left), maternally methylated Snrpn ICR (bottom left),
biallelic binding site within Pank4 gene intron on chromosome 4 (top right) and a strain-specific monoallelic binding within the Cmtm4 gene intron
on chromosome 8 (bottom right). Tracks in each panel show the following (top-down): histone modification profiles for H3K4me3, H3K9me3 and
H4K20me3 [28]; combined read densities for BC and CB ZFP57 ChIP; Bl6/Cast SNPs [24]; density plots for allele-specific reads in BC and CB ChIP;
position of known ICRs where found; annotated UCSC genes in the region
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clusively at known imprinted genes) and exons, including
3′ exon/untranslated regions of several zinc finger genes
(Fig. 2a). Amongst repeat elements, ZFP57 peaks were de-
pleted at SINEs (short interspersed nuclear elements) and
LINEs (long interspersed nuclear elements) but not long
terminal repeat (LTR) elements, including five enriched
intracisternal A particles (column W in Additional file 2).
This is consistent with the previously ascribed roles for its
partner KAP1 in regulating zinc finger protein genes via
3′exons [26] and the silencing of endogenous retroviral el-
ements, such as intracisternal A particles, in ES cells [27].
Our data suggest that ZFP57 is, at least in part, involved
in targeting KAP1 to these elements in addition to its role
in maintaining methylation imprints.
Published datasets for genome-wide epigenetic states
in ES cells [28] were used to generate comparative con-
sensus profiles for histone modifications over and around
ZFP57 binding sites at both the imprinted germline DMRs
and other target sites. ZFP57 targets were found to be
strongly associated with both active (H3K4me3) and re-
pressive (H3K9me3/H4K20me3) histone marks over the
imprinted DMRs, but had only the repressive marks over
non-imprinted regions (Fig. 2b). Given that H3K4me3
modification is normally associated with the unmethylated
allele of imprinted germline DMRs [28–30] and ZFP57
targets the opposite methylated allele, we conclude that
ZFP57 binding is largely associated with repressive marks,
consistent with its ability to recruit the KAP1 co-repressor
complex that includes the histone H3K9 methylase
SETDB1. Furthermore, the shape of the profile suggests
that ZFP57 acts as a nucleation site for H3K9me3Table 1 Summary of ASAP read alignments
BC_Zfp57 CB_Zfp57 BC_input CB_input
Total reads 30,194,924 29,235,782 31,025,973 30,133,611
Common aligned 11,292,411 15,300,444 16,466,916 15,791,179
Bl6-aligned 1,122,729 1,919,283 1,365,545 1,302,297
Cast-aligned 1,067,237 1,875,100 1,314,585 1,292,906
Ratio BL6/Cast 1.05 1.02 1.04 1.01deposition and spreading that is then closely followed by
appearance of the H4K20me3 mark at either side of
H3K9me3.
As ZFP57 has been shown to be a DNA methylation
maintenance factor both in the embryo and in ES cells
[19, 21, 22], we investigated if ZFP57 peaks are generally
associated with methylated regions in the genome in ES
cells. We utilized available ES cell methylation data [31]
and compared the methylation levels of CpG islands
(CGIs) bound by ZFP57 with an equal pool of randomly
selected unbound CGIs (Fig. 2c). As expected, unbound
CGIs were unmethylated while ~40–60 % methylation
was observed for the imprinted DMR-associated CGIs.
The majority of non-imprinted CGIs bound by ZFP57
were completely or partially methylated, consistent with
its methyl-sensitive binding and a role in maintaining
DNA methylation. Of note, however, public datasets
used for comparison were generated from serum-grown
ES cells, whilst the hybrid ES cells used in our study
were adapted to 2i LIF conditions. Finally, we also ana-
lyzed public reduced representation bisulfite sequencing
and BS-seq datasets for germ cell and blastocyst DNA
methylation [32, 33] and found that CGIs targeted by
ZFP57 in ES cells are also normally methylated in the
oocyte and retain methylation marks in pre-implantation
blastocysts (Fig. S4 in Additional file 1).
Our DNA sequence analysis around ZFP57 bound
sites has identified a heptamer TGCCGCN consensus
binding motif (Fig. 4a) consistent with a hexamer de-
scribed in a previous report [21] with a preference for a
purine (R) rather than a pyrimidine (Y) base in the sev-
enth base. (columns K and L in Additional file 2). This
heptamer motif is often present in multiple copies. The
degree to which the last base affects the ZFP57 binding
affinity remains to be elucidated, however.
Parental allele-specific Zfp57 peaks exclusively mark
ICR elements
Allele-specific analysis of ZFP57 targets revealed 23 mater-
nal and one paternal chromosome-specific instance of
allele-specific ZFP57 binding (Fig. 1b), which mapped ex-
clusively within known imprinted germline DMRs
Table 2 Summary of ZFP57 binding within ICRs
Chr Start End Gene ChIP-seq peaks TGCCGCR motif TGCCGCY motif ChIP-seq allele SNP-Pyro allele
1 63246657 63247300 Gpr1 1 1 2 Mat Mat
1 63305566 63315360 Zdbf2 - - 2 - -
2 157385609 157387535 Nnat/Peg5 1 4 2 N/A ND
2 152512421 152513169 Mcts2 1 3 - Mat ND
2 174119863 174126564 Gnas_ProXL 2 7 7 Mat Mat
2 174150877 174154638 Gnas_Ex1A - - 4 - -
5 135825859 135825980 Fkbp6 1 1 - Bi Bi
6 4696743 4699483 Peg10 1 3 - N/A ND
6 30684932 30689966 Mest 3 8 4 Mat ND
6 58856396 58857391 Nap1l5 1 4 1 N/A ND
7 67147381 67151583 Snrpn 3 9 1 Mat Mat
7 6679787 6684257 Peg3 2 7 1 Mat Mat
7 135830870 135832249 Inpp5f_v2 2 6 - Mat ND
7 149764673 149771930 Igf2/H19 1 5 1 N/A Pat
7 150480736 150482810 KvDMR1 1 3 - Mat Mat
8 125387861 125390344 Cdh15 1 2 - Bi ND
9 89767090 89775128 Rasgrf1 1 5 4 N/A Pat
10 12809697 12812131 Zac1 1 6 - Mat Mat
12 110762703 110773093 IG-DMR 1 8 2 Pat Pat
11 11925127 11927100 Grb10 1 3 1 Mat Mat
11 22871610 22874212 Zrsr1 2 - 2 Mat ND
15 72639707 72641342 Peg13 3 5 - Mat ND
17 12934169 12935816 Igf2r 4 7 1 Mat ND
18 13130435 13133510 Impact 2 5 - Mat ND
For each locus, the number of ZFP57 ChIP-seq peaks, underlying TGCCGCR/Y binding motifs and allele-specificity are shown. Start and end points of germline
DMRs are taken from [31, 32, 40]. All coordinates are NCBI/mm9 genome assembly. Bi biallelic Zfp57 binding at Cdh15 DMR consistent with biallelic methylation
reported in ES cells [40], Mat maternal, N/A no available SNPs to distinguish allele specificity, ND pyrosequencing assay not conducted for this locus, Pat paternal
Strogantsev et al. Genome Biology  (2015) 16:112 Page 5 of 18(Table 2). Figure S5 in Additional file 1 shows UCSC
genome browser views for all instances of parental
allele-specific binding of ZFP57 in addition to examples
shown in Fig. 1b. Interestingly, these parental allele-
specific peaks alone can independently define 15 of 21
known imprinted germline DMRs [33]. The other
known imprinted regions were also strongly associated
with ZFP57 binding, but lacked informative allele-
specific reads to distinguish their parental origin
(Table 2). Critically, within imprinted regions, ZFP57
targeted only germline DMRs and not secondary som-
atic DMRs that are established after fertilization as a
consequence of the germline DMR. Furthermore,
within the Gnas imprinted cluster, which harbors two
germline-derived DMRs, ZFP57 was found to specific-
ally associate with the one acting as the principal ICR
for the region [14].
We validated parental allele-specific binding at several
germline DMRs using independent ChIP assays followed
by quantitative SNP pyrosequencing across BL6/Castvariant bases (Fig. S6 in Additional file 1). In addition,
we experimentally identified SNPs within the two other
paternally methylated (Igf2-H19 and Rasgrf1) ICRs and
found that our profiled ZFP57 peaks were bound on
the normally methylated paternal allele (Fig. S6 in
Additional file 1).
Recently it has been shown that the regional extent of
methylation at the two paternally methylated ICR ele-
ments at Dlk1-Dio3 and H19-Igf2 is reduced during
genome-wide demethylation in pre-implantation devel-
opment stages, leaving only a core region protected from
methylation reprogramming [34, 35]. The positions of
ZFP57 binding coincide with the boundaries of the core
protected regions in both ICRs, consistent with the role
of ZFP57 in maintaining DNA methylation (Fig. S7 in
Additional file 1). Interestingly we also find that most
ZFP57-bound germline DMRs harbor clusters of two or
more consensus motifs, suggesting that multiple ZFP57
molecules may be recruited to regions within a DMR
(Table 2).
Fig. 2 Epigenetic modifications around ZFP57 peaks. a Overlap of ZFP57 peaks with Ensembl annotated gene features (left) and repeat elements
(right). Selective enrichment/depletion of ZFP57 peaks are compared against an average of ten independently generated boot-strap sets (Control).
b Plot of cumulative read counts for three different histone modifications around ZFP57 peaks found at imprinted germline DMRs and elsewhere.
Shown are H3K4me3, H3K9me3 and H4K20me3, and pan-H3 representing overall histone density. c Average DNA methylation at CGIs bound by
ZFP57 at ICRs and other non-imprinted loci compared with a randomly selected set of similar size. Data points represent individual CGIs with a
horizontal line showing median value for the group. Previously published ES cell reduced representation bisulfite sequencing methylation data
were used for this analysis [31]. Non-parametric Kruskall-Wallis tests were performed with significantly different categories denoted (***P < 0.001)
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imprinted genes
At least three studies have now profiled the methylomes
of mouse germ cells and early embryos, identifying more
than 100 novel germline DMRs that might potentiallyconstitute novel ICRs [32, 33, 36]. Given the specificity
of ZFP57 binding for ICR elements, we hypothesized
that those bound by ZFP57 are most likely to be regulat-
ing genomic imprinting. Genomic regions showing dif-
ferential methylation between egg and sperm (≥75 % in
F4
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retained ≥40 % methylation at blastocyst stage (data taken
from [32, 33]) were assessed for ZFP57 binding sites.
Reassuringly we could identify most known imprinted
germline DMRs using this approach, including the re-
cently reported maternally methylated germline Gpr1
DMR on chromosome 1 (Gpr1-Zdbf2 cluster) [33, 37, 38]
and Cdh15 DMR on chromosome 8 [39–41]. Interestingly,
no Zfp57 binding was observed to the paternally methyl-
ated germline DMR in the Gpr1-Zdbf2 imprinted locus,
which is not the predicted ICR [42, 43]. The Gpr1 DMR is
associated with expression of a long non-coding RNA iso-
form of the Zdbf2 gene (Zdbf2linc/Liz) that we and others
find to be imprinted and paternally expressed in extra-
embryonic tissues (Fig. S8 in Additional file 1) [37].
Of the remaining novel imprinted gene candidates, we
were able to design assays to test imprinting of three genes
(Nbas, Zfp444 and Fkbp6), analyzing their allele-specific ex-
pression in a panel of tissues isolated from reciprocal hy-
brid BC and CB conceptuses at embryonic day (E)16.5.
While expression of Nbas and Zfp444 was biallelic in all tis-
sues tested (data not shown), Fkbp6 showed clear
imprinted, paternal allele-specific expression in all embry-
onic stage tissues with highest levels observed in placenta
(Fig. 3b). Highest overall expression levels were found in
adult testis, consistent with a previous report [44], however,
in that tissue we found expression to be biallelic. We ruled
out the possibility that the observed imprinting can be a re-
sult of a technical artifact amplifying transcripts expressed
at low levels using a serial dilution of testis cDNA, showing
that Fkbp6 levels in embryonic tissues are still within a lin-
ear range of amplification and that allele-specific analysis
using SNP pyrosequencing is accurate at a wide range of
starting concentrations (Fig. S9A in Additional file 1). We
also tested whether imprinted expression extended to the
neighboring Trim50 gene, but found biallelic expression in
all tissues analyzed (data not shown).
We tested if the observed imprinted expression of Fkbp6
is associated with a constitutive DMR at the promoter. First,
using allele non-discriminatory quantitative bisulphite pyro-
sequencing, we determined that the ZFP57 binding site in
Fkbp6 is an oocyte methylated germline DMR in vivo that is
selectively maintained in placenta (~50-60 % overall methy-
lation), but becomes hypermethylated (~80-90 % methyla-
tion) in embryo and adult somatic tissues (Fig. 3c; Fig. S9B
in Additional file 1). We next determined allele-specificity of
methylation using M. m. Cast polymorphism (rs13487942),
which confers a Cast genome-specific CpG dinucleotide ad-
jacent to Fkbp6 transcription start site. Consistent with the
DMR status in placenta, this CpG was predominantly meth-
ylated when inherited on the maternal chromosome and
hypomethylated when inherited on the paternal chromo-
some (Fig. 3d). Therefore, unlike most canonical ICRs,
Fkbp6 is not fully methylated or unmethylated on either ofthe parental alleles, perhaps indicating that only a subset of
cells within the placenta have imprinting control. In addition
to DNA methylation we also analyzed histone modification
profiles around the Fkbp6 promoter (Fig. 3e). Consistent
with the observed expression pattern, an active H3K4me3
mark was found to be highest in the placenta and lowest
in brain, whilst the opposite was observed for the repres-
sive H3K9me3 mark. Allele-specific analysis clearly
showed paternal chromosome enrichment for H3K4me3
even in brain and liver samples and was consistent with
the observation of low, albeit still, imprinted Fkbp6 ex-
pression in these tissues, demonstrating the sensitivity of
this approach (Fig. 3b, e).
Interestingly, in the ES cells, the ZFP57-bound promoter
peak was biallelic on a generally hypomethylated allele and
the Fkbp6 gene was robustly expressed from both chromo-
somes (Fig. 3a,b). Promoter methylation was comparable to
that of testis (Fig. S9B in Additional file 1). We hypothesize
that the loss of germline methylation memory is a result of
in vitro ES cell culture. However, in vivo the Fkbp6 pro-
moter region constitutes a novel imprinted germline DMR
associated with widespread imprinted expression of this
gene. Tissue and/or developmental stage-specific imprinting
of other candidate genes found to be biallelic in our analysis
cannot be ruled out. In conclusion, our data indicate that
ZFP57-bound germline DMRs serve as a good predictor of
genomic imprinting.
Genetic variation can determine monoallelic expression
via ZFP57
Analysis of allele-specific ZFP57 binding revealed a subset of
monoallelic peaks that were associated with either the BL6
(17) or Cast (9) allele regardless of parental origin (Fig. 1b).
We hypothesized that these might have arisen through
strain-specific genetic variation in the binding motifs
(Fig. 4a). We successfully sequenced 22 out of 26 ZFP57-
bound regions from pure C57BL/6 and Cast/EiJ animals
and identified intact and disrupted motifs present on bound
vs. unbound alleles for each peak (Additional file 3). Individ-
ual motifs were considered to be disrupted even if a single
base pair change occurred anywhere within the heptamer
motif sequence (Additional file 4) [21, 45]. Given that many
peaks contain multiple motif instances, we categorized each
site as follows: all motifs disrupted (no intact motifs on un-
bound allele); some motifs disrupted (at least one intact
motif remaining on unbound allele); and all motifs intact
despite apparent monoallelic binding (Fig. 4b). Surprisingly,
we identified only five peaks with all motifs disrupted. Eight
regions had only some motifs disrupted and in seven regions
the genetic variation did not affect the motif sequence at all,
but was located outside adjacent to it (Fig. 4b).
Examination of the motif-disrupting SNP types indi-
cated that the majority were single base substitutions
found in different positions of the motif with the highest
A B
C
D
E
Fig. 3 (See legend on next page.)
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Fig. 3 Identification of Fkbp6 as a novel imprinted gene. a The Fkbp6 gene region with the location of ZFP57 binding within the promoter regions.
PSQ1 and PSQ2 denote regions analyzed by bisulphite pyrosequencing shown in (c). b Fkbp6 expression levels and allele-specificity in mouse tissues
and ES cells from quantitative RT-PCR and SNP pyrosequencing. The height of each bar represents Fkbp6 mRNA levels normalized to 18 s rRNA and
shown relative to liver expression levels. Blue and red stacked bars show relative contribution of BL6 and Cast alleles, respectively, to overall Fkbp6 levels.
Upper and lower error bars correspond to standard deviation between biological replicates for PCR and pyrosequencing analysis, respectively
(n = 8 replicates per each tissue: 4 BC and 4 CB; n = 4 for ES cell lines (ESCs). c The Fkbp6 promoter is not a somatic DMR. Quantitative bisulphite
pyrosequencing analysis of the Fkbp6 promoter region, which assays overall methylation level in the population of cells in a non-allele-specific manner.
Relative proportions of black (methylated) and white (unmethylated) filled areas in circles depict average percentage methylation for individual CpGs
(n = 4; 2 BC and 2 CB bioreplicates for each tissue type). Numbers adjacent show median percentage methylation values across CpGs covered by PSQ1
and PSQ2 sequencing primers. Grey circles denote CpGs not covered in the assay. Black arrow denotes Fkbp6 transcription start site and direction of
expression. Grey arrow underneath indicates position of the Cast-specific CpG (SNP rs13487942), quantified in (d). d Left: Bar chart showing methylation
status of the CpGCast when inherited on paternal (BC cross, blue bars) and maternal (CB cross, pink bars) chromosomes. Data from pyrosequencing of
adult testis, E16.5 brain and placenta, n = 2 × BC and 2 × CB samples per tissue. Right: Representative bisulphite pyrograms from individual BC and CB
placenta tissues. CpGCast region is framed in red, methylation level is calculated from the relative height of ‘T’ (unmethylated, Um) and ‘C’ (methylated, Me)
peaks. e Top: Relative enrichment of H3K4 and H3K9 tri-methylation in E16.5 tissues. Data shown relative to input and normalized to a reference
non-enriched genomic location. Bottom: Allele ratios from SNP pyrosequencing of ChIP-enriched DNA. Error bars reflect standard deviation between
three technical replicates for each sample shown
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Other disruptions included deletions of the entire motif
or part thereof and, in one instance, a 3 bp insertion
within the motif (Fig. 4c).
Given that, in multiple cases, SNPs within the motif
sequence alone could not explain the strain-specific
ZFP57 binding, we predicted that genetic variation out-
side the motif might determine the methylation state of
the motif and in turn explain strain-specific binding at
these sites (Fig. 4d). To test this we conducted parallel
independent ZFP57-ChIP and methylated DNA immu-
noprecipitation (MeDIP) assays (Fig. 5) followed by SNP
pyrosequencing of precipitated regions. The ratio of BL6
to Cast alleles was quantified and in each case we were
able to confirm strain-specific ZFP57 binding. In five of
six cases tested the region was also associated with dif-
ferential methylation. This included a ZFP57 peak C1 at
the 3′ end of Zfp553 (Fig. 5b, left middle chart), which
had intact motifs on both alleles but was associated with
DNA methylation and ZFP57 binding specifically on the
Castaneus sequence. We suggest that the strain-specific
differential methylation in these instances may be genet-
ically conferred, perhaps by neighboring genetic variants.
We next determined whether the strain-specific genet-
ically determined monoallelic binding, could be associ-
ated with the expression of 19 genes adjacent to these
sites. Allele-specific expression was investigated using
four different reciprocal hybrid ES cell lines and neural
stem (NS) cell progenitors derived from them. Data
identified eight genes in ES cells with significant strain-
specific allele expression bias (Fig. 6, Table 3; Fig. S10 in
Additional file 1). Four of these (Efhd2, Arhgef10,
Trim67 and Sdk2) were upregulated and became biallelic
upon neural differentiation. Three (Ube2w, Fam89a and
4933422H20Rik) retained allele bias upon differentiation
and one (Zfp553) was downregulated and becamebiallelic in NS cells. The remaining genes were equally
expressed from both alleles or showed minimal skews
(<15 % median skew relative to genomic DNA control;
Table 3; Fig. S10 in Additional file 1). There was no ob-
vious pattern relating the position of the ZFP57-bound
region and the relative allelic activity. For example, while
Zfp57 binding at the Cast allele of the Zfp553 gene was
associated with BL6-specific expression, the Sdk2 gene
showed preferential expression from the ZFP57-bound
Cast allele.
Discussion
We and others have recently focused on the role of
ZFP57 and KAP1 in the maintenance of DNA methyla-
tion in early mouse embryo development [19, 21–23].
In the current work we extend these studies by per-
forming parental-origin allele-specific analysis of en-
dogenous ZFP57 binding using reciprocal hybrids.
Critically, unlike previous studies, we distinguish mono-
allelic binding determined by parental origin effects
(imprinted germline DMRs) from those determined by
underlying sequence variation.
We identified ZFP57 binding within all known
imprinted regions, where it specifically targets the
methylated allele of germline but not somatically meth-
ylated DMRs. In fact all parental allele-specific peaks lie
exclusively within well-established or recently reported
imprinted germline DMRs. Most ZFP57 sites are associ-
ated with peaks of repressive H3K9 and H4K20 tri-
methylation, and recruitment of KAP1 and associated
SETDB1 H3K9-specific histone methyltransferase to these
regions. In addition, peaks of active H3K4me3 modifica-
tion were present solely at the imprinted germline DMRs,
where they are associated with the opposite unmethylated
allele, consistent with these three marks being hallmarks
of ICRs in ES cells [29, 46]. A larger proportion of ZFP57
Fig. 4 Genetic analysis of ZFP57 consensus binding motif. a Consensus ZFP57 binding motif identified using MEME algorithm analysis of DNA
sequences underlying ChIP-seq peaks. b Distribution of genetically determined monoallelic Zfp57 peaks based on motif integrity on the unbound
vs. bound alleles: SNPs disrupting all of the motifs (five sites, red), some of the motifs with at least one remaining intact (eight sites, orange) and
none of the motifs (seven sites, green). No motifs could be found on either genetic alleles in two cases (grey). c Diagram indicating which bases within
the consensus are varied between BL6 and Cast genomes in strain-specific peaks. Long bars, short bars and triangle indicate deletion, SNP and insertion
events, respectively. d Putative mechanisms for ZFP57 allele-specific binding. Top: ZFP57 bound, motif intact and methylated. Bottom left: ZFP57 does
not bind because motif is mutated. Bottom right: ZFP57 does not bind because motif is unmethylated in a given genetic background
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particular, found within gene exons and introns and fre-
quently overlap LTRs corresponding to endogenous
retroviral (ERV) insertions (columns V and W in
Additional file 2). These are targeted by KAP1, which is
necessary to silence ERVs in mouse ES cells [26, 27, 47],
suggesting that silencing at these loci is targeted, at least
in part, by ZFP57.
ZFP57 occupancy at identified genomic location, how-
ever, does not constitute a biochemical assay of function.For instance, whilst we and Quenneville et al. [21] ob-
serve ZFP57 binding to all known germline ICRs, only a
subset of these is hypomethylated in the Zfp57 null em-
bryos even in maternal zygotic mutants [19]. This might
be explained by redundancy mediated by other KRAB-
ZFPs that could potentially recruit KAP1 to the un-
affected ICRs or through action of other factors such as
PGC7/Stella [48]. Alternatively, in the absence of ZFP57
binding, kinetics of DNA methylation loss may vary be-
tween different ICRs. As there is only a finite window of
Fig. 5 Validation of strain-specific sites. a Independent ChIP-quantitative PCR validation of Zfp57 binding to non-imprinted monoallelic peaks.
Overall enrichment levels are shown relative to negative control region (REF) and normalized to non-specific IgG pull-down. b Allele-specific
analysis using SNP pyrosequencing of ChIP and 5mC-DIP enriched DNA showing Zfp57 binding is directed by both underlying DNA sequence
and methylation status of the allele. Error bars represent standard deviation between three technical replicates
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DNA demethylation wave could potentially target im-
prints, some ICRs may retain sufficient methylation to
allow recovery. Indeed at the H19 locus there is evidence
for stochastic loss of methylation in embryos derived from
KAP1 null oocytes [23, 49]. Finally, loss of DNA methyla-
tion may be secondary to loss of histone H3K9 tri-
methylation in the absence of KAP1-SETDB1 recruitmentto ICRs. Levels of H3K9me3 at ICRs has not been ana-
lyzed in pre-implantation embryos.
There is considerable interest in determining the full
imprinted complement of the mouse genome and in
identifying novel imprinted genes. Given that all murine
imprinted clusters identified to date contain a germline
DMR, one can also survey the DNA methylation in egg,
sperm and early embryos to identify candidate imprinted
Fig. 6 Strain-specific expression bias at genes around non-imprinted Zfp57 peaks. Allelic activity and expression level for eight genes found to
have significant allelic bias in hybrid ES cells (ES, clear dots) and their neural stem cell derivatives (NS, filled dots); see also Fig. S10 in Additional
file 1 and Table 3. The corresponding genomic DNA standard (expected 50 % allele composition) used to control for PCR bias and pyrosequencing
artifacts is shown as a fitted linear regression (red dotted line). Allelic composition found by SNP pyrosequencing is plotted along the y-axes as
percentage of BL6 expression (0 % = pure Cast, 100 % = pure BL6 and 50 % = perfect biallelic) and overall expression level by quantitative
RT-PCR is plotted along the x-axes as absolute levels of the control hybrid genomic DNA (log2 nanograms/PCR). The title in each graph shows gene
name and closest associated ZFP57 peak along with its relative position with respect to the gene. Note that for Sdk2 a dilution series of neural stem
cell cDNA (high level biallelic expression) was used as a control since the relevant exon boundary panning primers could not amplify genomic DNA
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1000 CGIs are hypermethylated in mature oocyte and
hypomethylated in sperm, of which only ~15 % retain
methylation in the blastocyst [32, 33]. This still providesover 100 novel putative candidate imprinted clusters.
We hypothesized that those bound by ZFP57 may repre-
sent bona fide ICRs for novel imprinted genes. Overlap-
ping ZFP57 peaks with these extended germline DMRs
Table 3 Relative allele usage in expression of genes neighboring strain-specific ZFP57 peaks
Genomic DNA cDNA ES cells cDNA NS cells
Gene Zfp57 peak BC2 BC8 CB4 CB9 BC2 BC8 CB4 CB9 ANOVA BC2 BC8 CB4 CB9 ANOVA
B2_Nhlrc1 3′ intergna 38 % 35 % 32 % 38 % 28 % 21 % 38 % 39 % NS - - - - -
B3_Talpid3 Intron 51 % 52 % 51 % 50 % 51 % 51 % 51 % 51 % NS 54 % 52 % 52 % 53 % *
B4_Cmtm4 Intron 49 % 52 % 49 % 48 % 54 % 55 % 52 % 52 % * 47 % 50 % 47 % 49 % NS
B7_Efhd2 3′ intergn 52 % 53 % 59 % 56 % 37 % 37 % 40 % 38 % *** 53 % 55 % 53 % 57 % NS
B8_Arhgef10 Intron 42 % 45 % 41 % 40 % 31 % 27 % 26 % 28 % *** 40 % 39 % 39 % 40 % NS
B10_Fam89 3′ intergn 52 % 48 % 47 % 47 % 84 % 83 % 80 % 87 % *** 93 % 92 % 94 % 88 % ***
B10_Trim67 5′ intergn 45 % 48 % 45 % 46 % 64 % 75 % 84 % 84 % ** 47 % 53 % 47 % 58 % NS
B12_Nbas Intron 53 % 44 % 54 % 54 % 66 % 48 % 65 % 66 % NS 53 % 44 % 54 % 54 % NS
B13_Ankrd6 Intron 49 % 49 % 47 % 51 % 52 % 51 % 54 % 55 % NS 41 % 43 % 37 % 44 % **
B15_Btbd11 Intron 58 % 59 % 59 % 57 % 56 % 57 % 57 % 52 % NS 53 % 54 % 57 % 57 % NS
B16_Ccdc11 5′ intergn 51 % 51 % 52 % 53 % 62 % 71 % 62 % 66 % * 62 % 60 % 62 % 47 % NS
C1_Zfp553 3′ exon 36 % 35 % 36 % 34 % 73 % 78 % 73 % 75 % *** 39 % 39 % 39 % 43 % *
C2_Sdk2 Intron - - - - 12 % 11 % 20 % 20 % ** 59 % 56 % 50 % 56 % NS
C3_Qrsl1 Exon 50 % 46 % 45 % 48 % 46 % 49 % 51 % 49 % NS 47 % 48 % 50 % 49 % NS
C4_Ube2w Intron 40 % 37 % 39 % 38 % 67 % 66 % 64 % 63 % *** 66 % 66 % 64 % 66 % ***
C5_Usp14 Intron 47 % 45 % 46 % 47 % 47 % 45 % 45 % 46 % NS 43 % 42 % 43 % 43 % *
C6_4933422H20Rik Intron 50 % 48 % 46 % 49 % 21 % 28 % 32 % 36 % ** 8 % 19 % 8 % 22 % ***
C7_Tmem86a 3′ exon 52 % 49 % 52 % 52 % 52 % 41 % 51 % 59 % NS 46 % 45 % 48 % 44 % NS
C8_Atrn Intron 41 % 37 % 37 % 37 % 45 % 42 % 43 % 47 % * 36 % 38 % 40 % 46 % NS
aIntergn intergenic ZFP57 binding upstream (5′) or downstream (3′) of the gene. Each row shows the gene name, position of the associated ZFP57 binding site
and percentage of BL6 allelic expression ascertained by SNP pyrosequencing (i.e., 100 % = exclusively BL6, 0 % = exclusively Cast and 50 % = perfect biallelic
expression). cDNA from four hybrid ES and neural stem cells was analyzed and compared with their corresponding genomic control for PCR bias (gDNA). Values
in bold font emphasize significant C57BL/6 or Cast preferential allelic expression (p < 0.01, median difference greater than 15 % compared with genomic DNA
control). For Sdk2, where no gDNA is available, ES cells are compared relative to neural stem cell expression. (*p < 0.05, **p < 0.01, ***p < 0.001 repeated
measures ANOVA with Bonferroni’s post-test; NS not significant). See also Fig. S10 in Additional file 1 and Fig. 6 highlighting the relative expression level and allelic
preference for eight highlighted genes.
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already been recently analyzed and Cdh15 reported as
imprinted [40]. We tested additional three and report
identification of another novel imprinted gene, FK506-
binding protein 6 (Fkbp6) on chromosome 5. Previously,
Fkbp6 has been identified as a testis-specific factor of the
meiotic synaptonemal complex, with mutant male but not
female mice being completely sterile [44]. Another study
has also implicated Fkbp6 in the piRNA biogenesis path-
way in male germ cells [50]. Fkbp6 expression is abundant
and not imprinted in adult testis, presumably as a result of
imprint reprogramming in the germline (Fig. 3b). In em-
bryonic tissues it is widely imprinted, with the most robust
expression being in the placenta. Further experiments are
necessary to uncover the functional relevance of Fkbp6
imprinting in placenta tissues.
In human patients with Williams syndrome carrying a
large multi-gene deletion on chromosome 7q11.23,
FKBP6 hemizygocity was found to contribute to hyper-
calcemia and growth retardation [51]. Growth retard-
ation in Williams syndrome has been associated with a
parental-origin effect [52]. Given recent reports thathuman ZFP57 recognizes the same DNA consensus motif
[53], we analyzed the promoter sequence of the human
FKBP6 gene and identified at least two putative ZFP57
binding motifs. ENCODE data suggest that the human
promoter CGI is methylated in most normal and cancer
human cell lines as well as adult brain tissue (Fig. S11 in
Additional file 1). Hence, akin to mouse, imprinting of the
human FKBP6, if it occurs, is likely to be tissue specific.
It has been demonstrated in vitro that ZFP57 zinc fin-
gers 2–3 are responsible for binding motif recognition
and have the highest affinity when a central CpG di-
nucleotide in the motif is fully methylated [21, 45]. Here
we demonstrate this in vivo for the endogenous full-
length protein, showing that ZFP57 always follows the
methylated allele in cases of both imprinted (Fig. S6 in
Additional file 1) and genetically determined allele-
specific binding sites (Fig. 5). We also identify the same
consensus binding motif sequence as Quenneville et al.
[21], noting a clear preference for purine (R) over pyr-
imidine (Y) as the last base of the heptamer motif (col-
umns K and L in Additional file 2). We note that in case
of guanine (around half of all motifs found) this creates
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tantly methylated with the central CpG in the motif. It
remains to be experimentally elucidated, however,
whether ZFP57 binds with higher affinity to the se-
quence TGCCGCR than TGCCGCY.
In situations where binding was abrogated in a strain-
specific manner, defects in the binding motif preferentially
fell within that central CpG. In monoallelic strain-
specific binding where the motif(s) itself is genetically
identical on both alleles, ZFP57 was again targeted to
the methylated allele (Fig. 5). In these instances, how-
ever, adjacent DNA polymorphisms were noted. Gen-
etic variation in cis has previously been shown to
influence CG methylation in mouse and human and
hence provides a likely explanation for this differential
methylation [54–57].
Much attention has focused on understanding the
mechanisms by which genetic variation can determine
divergence in gene expression levels. Expression quanti-
tative trait loci (eQTL) studies have shown that a large
proportion of genes can be influenced by particular gen-
etic variants [58]. A recent study found that approxi-
mately a quarter of genes expressed in mouse liver show
strain-specific differences in expression between C57BL/
6 and Cast/EiJ mice [59]. In our study we find a large
proportion of ZFP57 sites being targeted to either BL6
or Cast chromosomes regardless of parental origin. We
tested whether genes in the vicinity of these sites exhibit
skewed allelic expression and find that more than 40 %
(8/19) of the genes tested show significant preference of
one allele over the other in BC and CB hybrid ES cells
(Fig. 6; Fig. S10 in Additional file 1). Upon differentiation
into the neural lineage, Zfp57 mRNA levels are dramatic-
ally reduced and half of these genes become biallelically
expressed, whilst the other half remain expressed in a pre-
dominantly monoallelic fashion. Interestingly, ZFP57
binding and gene expression were not always inversely
correlated as would be predicted by recruitment of a re-
pressive KAP1 complex. Further analysis will determine
whether ZFP57 is directly responsible for the allelic bias in
these genes.
Conclusions
In the current study we present four novel findings.
First, we show that within 22 established mouse imprinted
clusters, ZFP57 specifically binds known or predicted ICR
elements in each of them, but does not interact with sec-
ondary somatically methylated DMRs or germline DMRs
that are not imprinting controlling. Second, we show that
ZFP57 binding can be efficiently used to predict novel
imprinted genes, identifying Fkbp6 as a gene whose ex-
pression is imprinted and paternal allele-specific in pla-
centa. Third, we show that many ZFP57 targets lie
outside imprinted clusters, have biallelic binding, arehypermethylated and are enriched in repressive H3K9me3
histone marks, consistent with KAP1 co-repressor recruit-
ment; members of this class include some ERVs where the
DNA binding factor targeting the repressive state had not
previously been identified. Finally, we show that genetic
and epigenetic variation can specify strain-specific mono-
allelic ZFP57 binding, which is often associated with
biased allelic expression of adjacent genes.
Materials and methods
Cell culture
Reciprocal hybrid mouse ES cells were derived in serum
replacement media as described previously [60] and
adapted to feeder-free-based 2i LIF culture conditions
(N2B27, Stem Cell Sciences) [61]. Monolayer neural differ-
entiation was induced by withdrawal of 2i and LIF supple-
ments using established protocols [62, 63]. Derived neural
stem cells were maintained in RHB-A media (Stem Cell
Sciences) supplemented with10 ng/ml of FGF-2 and EGF
(Peprotech). Research was conducted in accordance with
UK Home Office Animals Scientific Procedures Act, pro-
ject licence 80/2567.
Western blotting
Whole cell lysates prepared in 1× Laemmli buffer (10 μg)
were loaded in each well of a 10 % acrylamide gel. Follow-
ing transfer the blots were probed with rabbit anti-Zfp57
(Abcam, ab45341) at 1:5000 dilution or mouse anti-
Tubulin (SIGMA, T6199) at 1:10,000 dilution.
ChIP analysis
ChIP analysis of Zfp57 binding was performed on for-
maldehyde cross-linked chromatin isolated from ten 10-
cm dishes of hybrid mouse ES cells grown to ~70 %
confluency. Briefly, formaldehyde was added directly to
cell media to a final concentration of 1 % and dishes
were incubated at room temperature for 10 minutes
with agitation. The reaction was stopped by addition of
glycine to a final concentration of 0.125 M. The cells
were washed twice in ice-cold phosphate-buffered saline
(PBS), scraped into falcon tubes, centrifuged and resus-
pended in cell lysis buffer (0.25 % Triton X-100, 10 mM
EDTA, 0.5 mM EGTA, 10 mM Tris pH 8.0). Isolated nu-
clei were lysed in sonication buffer (50 mM Tris-HCl
pH 8.0, 10 mM EDTA, 0.5 % SDS) and sheared to an
average size of 200–500 bp using a Bioruptor sonicator
(Diagenode, UCD-200). Chromatin from ~5 × 106 cells
was diluted five-fold with IP buffer (1.1 % TX-100, 1.2
mM EDTA, 16.7 mM Tris pH 8.1, 167 mM NaCl) and
pre-cleared with 10 μg non-immune rabbit IgG and 50
μl of protein A magnetic beads (Dynabeads, Invitrogen)
for 3 h at 4 °C on a rotating wheel. Anti-Zfp57 antibody
(4 μg, abcam ab45341) or normal rabbit IgG was added
to pre-cleared chromatin and incubated overnight at 4 °C
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μl protein A beads for 3 h at 4 °C with rotation. The beads
were then washed in each of the following: buffer 1 (1 %
Triton X-100, 0.1 % SDS, 2 mM EDTA, 150 mM NaCl
and 20 mM Tris pH 8), buffer 2 (1 % Triton X-100, 0.1 %
SDS, 2 mM EDTA, 500 mM NaCl and 20 mM Tris pH 8),
buffer 3 (0.25 M LiCl, 1 % NP-40, 0.5 % sodium deoxycho-
late, 1 mM EDTA, 10 mM Tris pH 8) and twice with TE
buffer (10 mM Tris pH 8, 1 mM EDTA). The bound chro-
matin was eluted into elution buffer (1 % SDS, 0.1 M
NaHCO3), followed by crosslink reversal and protein di-
gestion. DNA was extracted by phenol/chloroform and
ethanol precipitated in the presence of 10 μg of glycogen.
One-tenth of the ChIP reaction was used for quantitative
PCR and SNP pyrosequencing analysis to control for ChIP
efficiency. The remainder was used for Illumina library
preparation.
Histone modifications were analyzed using native non-
crosslinking ChIP done on di- and tri- nucleosomal
preparations as described previously [64]. Mouse embryo
brain, liver and placenta tissues at E16.5 (F1 BL6/Cast
reciprocal hybrids) were analyzed using the following
antibodies: anti-H3K4me3 (Diagenode, C15410003);
anti-H3K9me3 (Abcam, ab8898) and anti-panH3 (con-
trol Abcam, ab1791).
Illumina library preparation and sequencing
Sequencing libraries were prepared from ~10 ng of ChIP
and 1 μg of input DNA using NEBnext® kit (E6260,
NEB) according to the manufacturer’s protocol. The
PCR amplified library was purified using Agencourt
AMPure magnetic beads for gel fragments size selected
at 150–400 bp. Each ChIP and input library was se-
quenced from a single end to a length of 40 nucleotides
on individual lanes of an Illumina Genome Analyzer IIx.
Allele-specific read alignment and detailed bioinformat-
ics analysis of data are outlined in Additional file 4.
Independent ChIP-quantitative PCR validation
To validate ChIP-seq peaks, we performed anti-ZFP57
ChIP experiments in independently grown ES cells used
for ChIP-seq (BC8 and CB9; Fig. S1 in Additional file 1)
as well as two additional reciprocal hybrid lines, BC2
and CB4. Pull-downs using non-immune rabbit IgG
were used to control for non-specific enrichments. ChIP
enriched DNA was analyzed in triplicate real time quan-
titative PCR reactions using SYBR-green chemistry
(LC480 instrument, Roche). The comparative Ct method
was used to calculate fold enrichment levels normalizing
to input DNA and non-specific IgG. In order to assess
statistically significant enrichment levels, we designed
primers for six locations not associated with the ZFP57
peak in the ChIP-seq data. Peaks having enrichment
levels three standard deviations above the mean of thenegative control were marked as confirmed. Primer se-
quences for each tested location are listed in Additional
file 5. Primers for quantitative PCR and SNP pyrose-
quencing analysis were designed using primer3 software
[65] and Pyromark Assay Design software (Qiagen). In
the case of the latter, one of the oligos was 5′ biotinyl-
ated to allow downstream processing (see below).
MeDIP analysis
Total genomic DNA was isolated from exponentially
growing ES cells. The cells were trypsinized, washed in
PBS, lysed in tail buffer (50 mM Tris, pH 8.0, 100 mM
EDTA, 100 mM NaCl, 1 % SDS) and incubated first with
RNase A for 10 minutes at 37 °C and then Proteinase K
overnight at 55 °C. DNA was extracted sequentially with
phenol, phenol-chloroform-isoamyl alcohol, chloroform
and then ethanol precipitated. For MeDIP, 1 μg of DNA
was sheared to an average size of 200–800 bp using a
Bioruptor sonicator (UCD-200, Diagenode) and incu-
bated overnight with 2 μg of anti-5methyl-cytosine anti-
bodies (Diagenode). The complexes were precipitated
using sheep anti-mouse IgG conjugated magnetic beads
(Invitrogen). The beads were washed three times with
binding buffer and eluted with proteinase K. Purified
DNA was subsequently PCR amplified using primers
listed in Additional file 5 and analyzed by quantitative
SNP pyrosequencing to determine the relative ratio of
each allele.
Reverse transcription and quantitative PCR assays
Total RNA was isolated using the TRI-reagent method
from either cultured cells or homogenized tissue, DNa-
seI treated and converted to cDNA using a RevertAid
first strand cDNA synthesis kit and random hexamer
primers (Fermentas). Quantitative PCR was performed
using SYBR-green chemistry on the Light Cycler 480 in-
strument (Roche). Three housekeeping genes (18S
rRNA, β-Actin and GAPDH) were used as a control. At
least two biological and three technical PCR replicates
were performed.
Pyrosequencing
Pyrosequencing was performed on a Pyromark Q96 MD
instrument and PyroMark Gold Q96 Reagents (Qiagen)
using the kit manufacturer's protocols and as described
previously [60]. Two types of assays were performed.
First, SNP pyrosequencing was used to measure the relative
allele ratio following RT-PCR (monoallelic gene expression
assessment) or following ChIP/MeDIP-quantitative PCR
measuring allele-specific enrichment of Zfp57 or 5-methyl
cytosine at given genomic locations. Primer sequences are
listed in Additional file 5.
Second, quantitative bisulphite CpG pyrosequencing
was performed in order to assess DNA methylation
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E16.5 conceptus tissues. Briefly, purified genomic DNA
was bisulphite converted using an imprint® DNA modifi-
cation kit (SIGMA), PCR amplified using Gpr1 and
Fkpb6 DMR-specific primers, and pyrosequenced on the
PSQ HS96 system (Qiagen) using pyromark CpG ana-
lysis software. PCR product preparation was performed
in the same way as for SNP pyrosequencing. The follow-
ing primer sets were used:
Gpr1 DMR: forward, AGGGTTATATTGAGAGAAAT
ATTGTG; reverse (5’ biotin), ATATTAAATTAAACCCT
AAATTCCATTTCT; sequencing, ATTTAAATTATTGA
TGTTTAAG. Sequence to analyze (CpG positions assayed
in bold): YGTATTTATTGTYGTYGTTTTGYGGTTTTG
TYGTTTTTATAGATGTTTTATTTTATYGYGGTATYG
TAYGGTAYGTTTTTG.
Fkbp6 promoter DMR: forward, GTTTTGTTAGA
AGTTTTTTTAGGGTTTTAT; reverse (5’ biotin), CTA
ACCTAAAATACCAACCCCTTCC; sequencing PSQ1,
AGTTTTTTTAGGGTTTTATTTTG; sequencing PSQ2,
GGGTAGTTTTAGGTAAGGTTTT. Sequence to analyze,
(CpGs in bold, BL6/Cast SNP rs13487942 in italics): PSQ1,
TTTTGYGTTTGTTATTAYGTGTGTAGYGYGTGTTG
GGAGATTTTTAGYGTATGTTYGTATGTTYGTTG;
PSQ2, TGGA/[T/C]GATAGTTGTGYGGTAAGATGA
GYGTTTTTTYGYGTTTTAGGAAYGGAATTTTATYG
TYGYGAGAYGATTGTTAGGTAYGGAGYGGGGTTY
GGG.
The Fkbp6 promoter region was amplified using the
above forward and reverse primers and pyrosequenced
sequentially using two sequencing primes. Genomic po-
sitions of CpGs covered by PSQ1 and PSQ2 sequencing
primers are indicated in Fig. 3a (bottom tracks).
Note, quantitative bisulphite pyrosequencing is a bulk
population assay measuring overall methylation levels and
as such is not allele-discriminatory. We could, however, de-
termine allele-specificity for one CpG, which was present
only in M. m. Cast genome (rs13487942). We initially
attempted conventional clonal bisulphite sequencing but
encountered strong cloning bias towards methylated alleles
even in generally hypomethylated tissues (testis and ESCs).
Analysis of monoallelic gene expression near
strain-specific ZFP57 binding sites
Assessment of allele specificity of gene expression was
performed using quantitative RT-PCR followed by SNP
pyrosequencing of the resulting product. The assays were
performed using cDNA from four hybrid ES cell lines (2
BC and 2 CB) and neural stem cells derived therefrom.
Genomic DNA corresponding to each cell line was used
as a reference for 50 %:50 % BL6/Cast allele percentage
relative to which skews in cDNA were analyzed (Table 3;
Fig. S10A in Additional file 1). A dilution series of the ref-
erence hybrid genomic DNA was constructed to controlfor PCR amplification and pyrosequencing biases at a wide
range of starting concentrations (2–0.25 ng/PCR).
Absolute expression level for each gene was quantified
against the reference genomic DNA standard and is repre-
sented as log2 (nanograms of standard/PCR) along the x-
axes in Fig. 6. Typically, 1 μl of a 1/20 cDNA dilution of the
1 μg RNA reverse transcription reaction were used per PCR.
Repeated measures ANOVA was used to compare median
allele ratios in cDNA relative to genomic DNA controls
(Table 3; Fig. S10 in Additional file 1). An arbitrary cutoff
was set for genes having p < 0.01 (Bonferroni post-test) and
an overall difference in median allele ratio ≥15 % (either to-
wards BL6 or Cast) relative to genomic DNA (eight genes
shown in Fig. 6).
In the case of allele-specific analysis of Fkbp6 and Sdk2
genes, due to position of informative SNPs, PCR primers
had to span exon boundaries and a reference hybrid gDNA
standard could not be used to test for bias. Instead we con-
structed standards using a dilution series of a cDNA where
we found these genes to be highly abundant and biallelic
(e.g., testis for Fkbp6 and neural stem cells for Sdk2). Using
this control we were able to demonstrate that monoallelic
expression (imprinted or genetically determined) did not
arise from random PCR amplification biases.
Data availability
Illumina sequencing data have been submitted to the
Gene Expression Omnibus database under accession
GSE55382.
Additional files
Additional file 1: Supplementary Figures S1–S11.
Additional file 2: Table S1. Zfp57 binding sites and their genomic
annotations.
Additional file 3: Genomic sequence alignments of C57BL/6 and
Cast/EiJ DNA around monoallleic Zfp57 binding sites.
Additional file 4: Supplementary methods.
Additional file 5: Table S2. Primer sequences used in the study.
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